Product Code: ETC332645 | Publication Date: Aug 2022 | Updated Date: Apr 2024 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The market for meningococcal vaccines in Argentina is witnessing growth, supported by government immunization programs and public health initiatives. Meningococcal vaccines protect against meningococcal disease caused by Neisseria meningitidis bacteria, addressing the need for preventive healthcare measures against bacterial meningitis outbreaks in the country.
The meningococcal vaccines market in Argentina is witnessing growth due to several driving factors. Firstly, the increasing awareness regarding the importance of vaccination in preventing meningococcal disease outbreaks is driving market growth. Meningococcal vaccines are crucial for protecting individuals against bacterial meningitis caused by Neisseria meningitidis bacteria. Moreover, the growing incidence of meningococcal disease and the potential for severe complications, including meningitis, septicemia, and death, are driving the demand for meningococcal vaccination in Argentina. Additionally, government initiatives to expand immunization programs and ensure vaccine availability to all population groups are further driving market growth.
The Argentina meningococcal vaccines market encounters obstacles that impact its development. One significant challenge is the limited awareness and understanding of meningococcal disease and vaccination among healthcare providers and the general public. Insufficient vaccination coverage rates and vaccine hesitancy further hinder market growth, leading to outbreaks and public health concerns. Moreover, competition from international vaccine manufacturers and regulatory constraints on vaccine procurement and distribution pose challenges for local vaccine producers to gain market share.
Argentina healthcare policies prioritize vaccination programs to prevent infectious diseases, including meningococcal meningitis. Government initiatives include procurement strategies, immunization schedules, and public awareness campaigns to ensure access to meningococcal vaccines and protect population health.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Argentina Meningococcal Vaccines Market Overview |
3.1 Argentina Country Macro Economic Indicators |
3.2 Argentina Meningococcal Vaccines Market Revenues & Volume, 2020 & 2030F |
3.3 Argentina Meningococcal Vaccines Market - Industry Life Cycle |
3.4 Argentina Meningococcal Vaccines Market - Porter's Five Forces |
3.5 Argentina Meningococcal Vaccines Market Revenues & Volume Share, By Product, 2020 & 2030F |
3.6 Argentina Meningococcal Vaccines Market Revenues & Volume Share, By Age Group, 2020 & 2030F |
3.7 Argentina Meningococcal Vaccines Market Revenues & Volume Share, By Distribution Channel, 2020 & 2030F |
4 Argentina Meningococcal Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Argentina Meningococcal Vaccines Market Trends |
6 Argentina Meningococcal Vaccines Market, By Types |
6.1 Argentina Meningococcal Vaccines Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Argentina Meningococcal Vaccines Market Revenues & Volume, By Product, 2020 - 2030F |
6.1.3 Argentina Meningococcal Vaccines Market Revenues & Volume, By Polysaccharide, 2020 - 2030F |
6.1.4 Argentina Meningococcal Vaccines Market Revenues & Volume, By Conjugate, 2020 - 2030F |
6.2 Argentina Meningococcal Vaccines Market, By Age Group |
6.2.1 Overview and Analysis |
6.2.2 Argentina Meningococcal Vaccines Market Revenues & Volume, By Infants, 2020 - 2030F |
6.2.3 Argentina Meningococcal Vaccines Market Revenues & Volume, By Children, 2020 - 2030F |
6.2.4 Argentina Meningococcal Vaccines Market Revenues & Volume, By Adolescents & Young Adults, 2020 - 2030F |
6.2.5 Argentina Meningococcal Vaccines Market Revenues & Volume, By Adults, 2020 - 2030F |
6.3 Argentina Meningococcal Vaccines Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Argentina Meningococcal Vaccines Market Revenues & Volume, By Pharmacies, 2020 - 2030F |
6.3.3 Argentina Meningococcal Vaccines Market Revenues & Volume, By Community Clinics, 2020 - 2030F |
6.3.4 Argentina Meningococcal Vaccines Market Revenues & Volume, By Public Health Agencies, 2020 - 2030F |
6.3.5 Argentina Meningococcal Vaccines Market Revenues & Volume, By Others, 2020 - 2030F |
7 Argentina Meningococcal Vaccines Market Import-Export Trade Statistics |
7.1 Argentina Meningococcal Vaccines Market Export to Major Countries |
7.2 Argentina Meningococcal Vaccines Market Imports from Major Countries |
8 Argentina Meningococcal Vaccines Market Key Performance Indicators |
9 Argentina Meningococcal Vaccines Market - Opportunity Assessment |
9.1 Argentina Meningococcal Vaccines Market Opportunity Assessment, By Product, 2020 & 2030F |
9.2 Argentina Meningococcal Vaccines Market Opportunity Assessment, By Age Group, 2020 & 2030F |
9.3 Argentina Meningococcal Vaccines Market Opportunity Assessment, By Distribution Channel, 2020 & 2030F |
10 Argentina Meningococcal Vaccines Market - Competitive Landscape |
10.1 Argentina Meningococcal Vaccines Market Revenue Share, By Companies, 2023 |
10.2 Argentina Meningococcal Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |